Theravance SVP Brett Grimaud Withholds 7,952 Shares for Taxes

What Happened

• Brett A. Grimaud, SVP, General Counsel and Secretary of Theravance Biopharma (TBPH), had 7,952 shares withheld on 2026-08-20 to satisfy tax obligations related to the vesting of previously granted restricted stock units (RSUs). The withholding was recorded at $16.95 per share for a total value of $134,786. This was a tax-withholding disposition by the issuer, not an open-market sale.

Key Details

• Transaction date: 2026-08-20; Filing date: 2026-08-24 (filed timely).
• Price per share: $16.95; Shares withheld/disposed: 7,952; Total value: $134,786.
• Shares owned after transaction: Not disclosed in the filing.
• Footnote: F1 — Shares were withheld to satisfy tax obligations arising from RSU vesting; the withholding was with the issuer and not an open-market transaction.
• Transaction code: F (payment of exercise price or tax liability).

Context

• This was a routine tax-withholding event tied to vested RSUs (a non-cash, issuer-side transaction). Such withholding transactions are common and do not necessarily indicate a change in the insider’s view of the company or represent an open-market sale of shares.